MGMT 275 Current Topics In Emerging Technologies: Healthcare Technology Easton Technology Leadership Program Winter 2014

Transcription

1 MGMT 275 Current Topics In Emerging Technologies: Healthcare Technology Easton Technology Leadership Program Winter 2014 Class Hours: Location: Instructors: Tuesdays 4:10 6:10 pm Entrepreneurs Hall, C315 Roy Doumani, JD Jennifer McCaney, PhD Course Overview The course will address the disruptive nature of emerging technology applications in healthcare. Topics covered will include digital health, electronic medical records, personalized medicine and diagnostics, wireless sensing and remote monitoring, cloud connectivity, telemedicine, mobile health platforms, social networks, big data and predictive analytics, and bioinformatics. The course will also include representatives from venture capital and the tech start- up community. The class is designed for MBA students as well as other graduate level students who are interested in healthcare or one of the many technology industries driving the transformation of healthcare. While previous training or experience in healthcare or technology is not required, students should feel comfortable reading about and discussing the technologies presented as they pertain to the healthcare industry. The objectives of this course are: (1) to achieve a comprehensive understanding of the current and future role of technology in healthcare; (2) to develop a predictive sense for how different technologies will affect the key stakeholders in healthcare patients, physicians, providers, payors, and the pharmaceutical/medical product industries; and (3) to identify management and business strategy challenges surrounding the implementation and utilization of technology in the healthcare industry. The course will consist of 10 sessions that are 2 hours in length. Instruction will combine a seminar format with guest speakers leading the sessions and discussion sessions facilitated by the course faculty to encourage student interaction. Preparatory readings are posted on the course website and required for each session to prepare students with an overview of the technology to be discussed and provide relevant business context. These readings are also necessary to participate in the class discussions, which are a substantial portion of the course grade. Additional

2 background references are available to those students with an interest in a particular technology area. Instructors Roy Doumani, Professor, UCLA School of Medicine Office: CNSI 5236 Assistant: Samantha Oughton (soughton@mednet.ucla.edu) roy@doumani.net Jennifer McCaney, Lecturer, UCLA Anderson School of Management Office: CNSI jmccaney@anderson.ucla.edu Grading Course grading will be divided between class participation and attendance and an individual deliverable, which will be the primary deliverable for the quarter. Class Participation & Attendance 35% Individual Deliverable 65% Networking Each week, networking opportunities with the guest speaker(s) will be available to groups of 4 to 6 students, either before or after class. Sign- ups will be provided online via the course website. Students are encouraged to sign up for a speaker networking session, however, participation is not mandatory and students with scheduling conflicts with not be penalized. Dinner will be provided. Course Deliverables Students will complete an individual deliverable and a final team presentation at the end of the quarter. Students will have two options for the individual deliverable: (1) a professional quality opinion paper on a technology topic presented in class; or (2) a business proposal for a new venture related to an opportunity created within any one of the healthcare technology markets discussed. During week 5 of the quarter, students will be asked to submit a one- paragraph summary of their individual deliverable topic, including the area of technology focus (not to exceed 250 words), which will be reviewed by the course faculty. This is due by 12pm on February 4 th to soughton@mednet.ucla.edu in the file name format Student Last Name_Student First Name_Summary. Students will be grouped into core technology teams based on the material submitted for this deliverable. Students will also have the option of submitting team member 2

3 preferences, which should be noted at the bottom of the page on their outline. Teams will be announced at class during week 6 on February 11 th. The final individual deliverable and copy of each team s presentation will be due by 12pm on Wednesday, March 11 th to soughton@mednet.ucla.edu in the file name format Student Last Name_Student First Name_Final Deliverable or Student Team Name_Final Presentation. Length: Individual paper not to exceed 5 pages, and team presentation not too exceed 10 slides or 10 minutes. The final student team presentations will take place in class on Wednesday, March 11 th. Please note that a hard copy of all materials is due in class on the date of the deliverable, however, materials received via after the 12pm deadline will be considered late. Class Schedule Session 1 Tuesday, January 7 th The Disruption of Healthcare & an Introduction to Digital and Mobile Health Guest Speaker: Jack Young, Director, Qualcomm Life Fund, Qualcomm Ventures J. Bigalke, W. Copeland, and P. Keckley, I m OK, Your re OK but Will We be All Right? Deloitte Review, no. 9, 2011 A Cure for Health- Care Costs, MIT Technology Review: Business Report, September 2013 E. Lee, 5 Ways Technology is Transforming Health Care, Forbes, pub. January 24, 2013 J. Nosta, 2013: The Year of Digital Health, Forbes, pub. January 1, 2013 The Dream of the Medical Tricorder, The Ecomonist, Technology Quarterly, pub. December, 1, 2012 Session 2 Tuesday, January 14 th Leveraging Technology & Innovation to Improve Patient Care Managed Care Perspective Faye Sahai, VP, Innovation & Advanced Technology, Digital Health Technology & Strategic Initiatives, Kaiser Permanente Karin Cooke, Manager, Innovation Fund for Technology, Kaiser Permanente 3

4 P. Groves et al., The Big Data Revolution in Healthcare: Accelerating Value and Innovation, McKinsey & Company: Center for US Health System Reform, Business Technology Office, January 2013 C. Hawn, One Step at a Time: Innovating at Kaiser Permanente, California Healthcare Foundation, March 2012 Z. Moukheiber, Kaiser Permanente Invites Software Developers to Build Apps, Forbes, pub. June 3, 2013 D. Talbot, Massive Gene Database Planned In California, MIT Technology Review, pub. October 21, 2009 E. Singer, Massive Project to Study the Link between Genetics and Health, MIT Technology Review, pub. July 26, 2011 Session 3 Tuesday, January 21 st Electronic Medical Records & Hospital Management Strategies for Healthcare IT Dr. Michael Pfeffer, Chief Medical Information Officer, UCLA Hospital Ellen Pollack, Chief Nursing Informatics Officer, UCLA Hospital G. Keston, Healthcare Information Management, Faulkner Information Services, 2013 G. Keston, Electronic Medical Records: Trends, Faulkner Information Services, 2013 A. Kellerman and S. Jones, What It Will Take to Achieve As- Yet- Unfulfilled Promises of Health Information Technology, Health Affairs 31, no. 1 (2013): pp. 1-6 D. Shaywitz, Is One Company About to Lock Up the Electronic Medical Records Market? The Atlantic, pub. June 14, 2012 Z. Moukheiber, Epic Systems Tough Billionaire, Forbes, pub. April 18, 2012 K. Mandl and I. Kohane, Escaping the EHR Trap The Future of Health IT, New England Journal of Medicine 366, no. 24 (2012): pp Session 4 Tuesday, January 28 th Telemedicine Meets Technology Remote Presence Monitoring Tim Wright, VP, Corporate and Market Strategy, InTouch Health Paul Vespa, MD, Professor of Neurosurgery and Neurology and Director of Neurocritical Care, UCLA Hospital 4

5 Y. Wang, Innovation in telemedicine technology: An entrepreneur's perspective, Healthcare IT News, May 6, 2013 E. Ackerman, irobot and InTouch Health Announce RP- VITA Telemedicine Robot, IEEE Spectrum, July 24, 2012 K. Greene, Advances in Health Care Bring Remote Expertise Close, U.S. News & World Report, July 12, 2013 T. Wright, The Financial Benefits of Acute Care Telemedicine, Healthcare Executive Insight, December 16, 2013 Telehealth and the Telemedicine Business Model Richard Boxer, MD, Managing Partner, Boxer Health Strategies and Former CMO, Teladoc, Inc. Telehealth Special Report: Health Care and Business, Teladoc, Inc., June 14, 2012 J. Graham, Top Health Trend For 2014: Telehealth To Grow Over 50%. What Role For Regulation? Forbes, December 28, 2013 D. Manos, Congress Introduces National Telehealth Bill, Government Health IT, December 20, 2013 A. Diznik, A Doctor's Visit Without the Cold Stethoscope, Wall Street Journal, August 6, 2012 Session 5 Tuesday, February 4 th Innovation in Drug Delivery Technology Adrian Bot, MD, PhD, VP, Scientific Affairs, Kite Pharma, Inc. and Former VP, Research, MannKind Corporation Mary Faris, PhD, MBA, Director, MannKInd Corporation TBD Session 6 Tuesday, February 11 th Analytical Approaches for Optimizing the Healthcare Ecosystem and IBM s Smarter Care Model 5

6 Guest Speaker: Leonard Lee, Industry Portfolio Manager, Healthcare, Life Sciences and Defense, IBM J. Cohn, The Robot Will See You Now, The Atlantic, March 2013 E. Blatt et al., Addressing Social Determinants and Their Impact on Healthcare, IBM Cúram Research Institute, 2013 H. Fraser et al., Analytics across the ecosystem: A prescription for optimizing healthcare outcomes, IBM Institute for Business Value, 2013 The Quantitative Self Personalized Fitness for the Mind Guest Speaker: Paul Campbell, CEO & Co- Founder, blife Inc. TBD Session 7 Tuesday February 18 th Personal Genomics Guest Speaker: Jon Ward, VP of Strategic Alliance, 23andMe Quantitative Advances Since the Human Genome Project (HGP), NIH News, pub. April 12, 2013 S. Lander, Initial Impact of the Sequencing of the Human Genome, Nature 470 (2011): pp T. Goetz, 23andMe Will Decode Your DNA for $1,000. Welcome to the Age of Genomics, WIRED 15, 2, pub. November 17, 2007 B. Rochman, Test Your DNA for Diseases- No Doctor Required, TIME, pub. October 23, 2012 S. Young, Why We Have a Right to Consumer Genetics, MIT Technology Review, pub. January 2, 2013 C. Bloss et al., Effect of Direct- to- Consumer Genomewide Profiling to Assess Disease Risk, New England Journal of Medicine 364, 6 (2011): pp andMe And the FDA, The Economist, pub November 30, 2013 L. Downes and P. Hunes, Regulating 23andMe to Death Won t Stop the New Age of 6

7 Genetic Testing, WIRED, pub. January, 1, 2014 Redefining Pharmaceutical R&D and an Introduction to Adaptive Clinical Trial Design Guest Speaker: Aubrey Kelly, Project Manager, Center for Operational Efficiency, Innovation, and Improvement, Amgen J. Cattell et al., How Big Data Can Revolutionize Pharmaceutical R&D, McKinsey & Company, April 2013 A. Dhankhar et al., Escaping the Sword of Damocles: Toward a New Future for Pharmaceutical R&D, McKinsey Perspectives on Drug and Device R&D 2012, 2012 M. Krams et al., Adaptive Approaches in Clinical Drug Development Opportunities and Challenges in Design and Implementation, Pharm Med (3): pp Session 8 Tuesday February 25 th Next Generation Sequencing Frank Oaks, VP, Sequencing Projects, Illumina Richard Shen, VP, Consumables Development, Illumina Susan Tousi, VP, Engineering, Illumina E. Mardis, A decade s perspective on DNA sequencing technology, Nature 470 (2011): pp Disruptive Technologies: Advances That Will Transform Life, Business, and the Global Economy, McKinsey Global Institute, May 2013: Introduction: Understanding the Impact of Technologies, pp Next- generation Genomics, pp An Introduction to Next- Generation Sequencing Technology, Illumina, 2013 T. Burton, FDA Approves New Gene- sequencing Devices, Wall Street Journal, Nov. 20, 2013 A. Regalado, 10 Breakthrough Technologies 2013: Prenatal DNA Sequencing, MIT Technology Review, April 20, 1013 L. Biesecker, Next- generation Sequencing in the Clinic: Are We Ready? Nature Genetics 13 (2012): pp

8 Session 9 Tuesday March 4 th Companion Diagnostics and the Outlook for Personalized Medicine Guest Speaker: Thai Lee, Product Manager, Ventana Medical Systems C. Learnon, Advancing the Promise of Personalized Medicine: Companion Diagnostics, Scientific American, pub. December 12, 2012 S. Kulkarni et al., Personalized Medicine: The Path Forward, McKinsey & Company, 2013 Managing for Success in Biomarker R&D: Challenges and Opportunities, pp Well Begun is Half Done: Success Factors for Companion Diagnostic Launch, pp Capturing Value for Dx in Personalized Medicine Is There a Path?, pp J. Davis et al., The Microeconomics of Personalized Medicine, McKinsey & Company, 2010 M. Hollmet, Roche Pairs Ventana Breast Cancer Test with Two More of Its Blockbuster Drugs, Fierce Medical Devices, pub. December 13, 2013 Social Network Platforms to Achieve Better Health Outcomes Guest Speaker: Derek Zabbia, EVP of Strategic Development, Audax Health J. Nosta, Are Insurance Providers Buying Into Digital Health? Audax Health Is Making It Happen, Forbes, pub. October 4, 2013 E. Singer, The Quantified- Self Business, MIT Technology Review, pub. September 22, 2011 CES Review Session 10 Tuesday March 11 th Student Final Presentations on Core Technology Opportunities 8